Five of the seven trials conform to the “gold standard” of clinical design in that they were randomized, double-blinded, placebo-controlled trials. Results show that EpiCor supports a strong, healthy immune system while it balances immune response; and significant measurable results can be seen in as little as two hours.
This paper recognizes the importance of clinical biomarkers in vivo biomarkers mentioned in this summary are from research conducted on healthy adult subjects.
Most of the biomarkers mentioned in this paper are also represented in a table at the end of the article.
This clinical trial, published in a MEDLINE-indexed journal, was double-blinded and placebo-controlled. Results include; a significant increase in Natural Killer (NK) cell activity within 2 hours of consumption.
Recent science shows that sIgA may also have other beneficial effects in overall immunity through reduced inflammation in the digestive tract. This paper will review sIgA’s known effects on mucosal immunity and describe the emerging research that shows its beneficial impact on digestive health.